why choose us

First received: December 09, 2022

Clinical Trial: Zuranolone Pharmacokinetics (PK) and Safety Study Adolescent Participants With Major Depressive Disorder (MDD)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Major Depressive Disorder

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Study to Evaluate the Pharmacokinetics and Safety of Zuranolone in Adolescents (12 to 17 Years of Age) With Major Depressive Disorder

Brief Summary: The primary purpose of this study is to evaluate the pharmacokinetics and safety of Zuranolone in adolescents (ages 12 to 17 years) with MDD.

Read more